Emma Reeve, Director at PTC THERAPEUTICS, INC. (PTCT), sold 1,466 shares at $78.62 ($115K) on 2025-12-03, disclosed to the SEC on 2025-12-05.
Scheduled sale ($115k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $78.62 | 733 | $58K | 50.0% |
| 2 | $78.62 | 733 | $58K | 50.0% |
| Total | $78.62 avg | 1,466 | $115K | 100% |
| Filing → |
| PTCT | SELL | 2025-11-14 | $1.1M | — | Filing → |
| PTCT | SELL | 2025-10-31 | $1.1M | — | Filing → |
| PTCT | SELL | 2025-10-07 | $3.4M | — | Filing → |